












Quin Wills
CSO at Ochre Bio
Quin Wills was the founder of Ochre Bio which went through YC in W20. Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
Follow Quin
Previously at

Novo Nordisk
Novo Nordisk Research Centre Oxford

University of Oxford

Mayo Clinic

SimuGen
UCL
Alumnus of

University of Oxford

University of Cambridge
University of the Witwatersrand (South Africa)